NanoSmart Technology

NanoSmart Breath-Sensor Technology

Transforming digital healthcare through groundbreaking new patent pending nano-enabled technology and sensor platforms that verify medications are ingested from your breath, on schedule, using a smart phone.

Whether we realize it or not, every day we consume billions of tiny, scientifically-engineered nanoparticles found in vitamins and naturally occurring found in food. Humans have been consuming nanoparticles in natural foods since prehistoric times, in milk and beer, for example.
Casein micelles in milk are nano-sized protein-calcium-phosphate particles produced naturally by a cow to deliver nutrition to her calf in a readily digestible form. And the polysaccharide compounds in beers are often nano-sized.

a widespread healthcare challenge

Conclusive studies show that poor technique and missed doses lead to significant additional costs, poor clinical outcomes, and serious complications even in experienced users. Diabetics and other injectable medicine users lead busy lives and need smart diabetic care tools to improve their health and wellness. Low medication adherence is arguably the most significant problem in our healthcare eco-system costing over $300 billion dollars in the USA alone and leading to over 125,000 premature deaths annually.
nGageIT’s PATENT PENDING NANOSMART ORAL ENCODING PLATFORM turns any approved oral dosage into a digital object. nGageIT’s NanoSmart Biosensor can detect a single, digitally encoded nano-particle from the more than 2,500 substances in the human breath.
nGageITs patent pending Nanosmart technology coats any oral medication with a molecular layer that acts like a barcode on each drug. These nanoparticles contain critical information such as the type of drug, lot number and time taken. nGageIT makes your medication smarter through our nanosmart technology.
To maximize the value of your molecule, you need an efficient, systematic approach that brings real-world data and patient perspectives into your clinical trial design process. nGageIT’s Nanopartical Biosensor can be used effectively in Phase III and IV clinical trails to mitigate the need for over sampling. This can save the Pharmaceutical industry millions of dollars for each trial and get their drugs to market quicker.

nGageIT aims to improve wellness in the healthcare ecosystem and solve the $564 billion global problem of lost pharma revenue due to non-adherence and disengaged patients. We are focused on the $34 billion niche in Specialty High Value Pharmaceutical market as well as the diabetic market.

how our technology works

nGageIT’s patent pending sensor technologies monitor when patients take either oral medications or give themselves medical injections at home.
This data is automatically uploaded to the cloud through the patient’s smart phone and can be tracked in real-time by health care providers and in clinical trials. This leads to better compliance with medical advice and medical device use, and better health outcomes for the patient.
The NanoSmart encoding particles can be safely integrated into current oral dosage coatings used by pharmaceutical manufacturers, minimizing any supply chain disruptions. A compatible app then provides information on dosage and sends automated reminders to the patient.
The patient can connect to their healthcare provider through video or live chat as needed. The pharmaceutical coating does not affect the performance of the tablet – it is simply used to coat the tablet.
predictive and proactive healthcare
Patients taking high value medications for serious conditions such as breast cancer or rare orphan diseases can now rely on nGageIT’s predictive dosing system to verify the ingestion of medication and seamlessly automate complex dosing schedules. Physicians and Providers are empowered by the medication usage data to precisely customize therapy to a patient’s lifestyle, behavior or genes.
More broadly, non-adherence is multi-factorial and must be addressed by understanding the underlying cause (e.g. side effects, lack of understanding of the disease, and dosing schedule). Providers lack accurate, timely adherence data necessary to diagnose non-adherence and its root cause and allow the patient and provider to respond quickly to poor adherence.
Once underlying causes are understood, preventative and proactive solutions tailored specifically to the patient and their care systems can be developed, increasing overall wellness, decreasing unwell states, and significantly minimizing personal and system healthcare costs.